AU2003250519A8 - Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures - Google Patents
Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell culturesInfo
- Publication number
- AU2003250519A8 AU2003250519A8 AU2003250519A AU2003250519A AU2003250519A8 AU 2003250519 A8 AU2003250519 A8 AU 2003250519A8 AU 2003250519 A AU2003250519 A AU 2003250519A AU 2003250519 A AU2003250519 A AU 2003250519A AU 2003250519 A8 AU2003250519 A8 AU 2003250519A8
- Authority
- AU
- Australia
- Prior art keywords
- hematopoietic stem
- vivo expansion
- stem cell
- cell cultures
- cell populations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/145—Thrombopoietin [TPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2005200679A AU2005200679B2 (en) | 2002-08-19 | 2005-02-16 | Ex-Vivo Expansion of Hematopoietic Stem Cell Populations in Mononuclear Cell Cultures |
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40414502P | 2002-08-19 | 2002-08-19 | |
US40413702P | 2002-08-19 | 2002-08-19 | |
US60/404,145 | 2002-08-19 | ||
US60/404,137 | 2002-08-19 | ||
IL15290402A IL152904A0 (en) | 2002-01-24 | 2002-11-17 | Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations |
IL152904 | 2002-11-17 | ||
PCT/IL2003/000062 WO2003062404A1 (en) | 2002-01-25 | 2003-01-23 | Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby |
AU2003208576 | 2003-01-23 | ||
PCT/IL2003/000064 WO2003062369A2 (en) | 2002-01-24 | 2003-01-26 | Expansion of renewable stem cell populations |
AUPCT/IL2003/000064 | 2003-01-26 | ||
US45254503P | 2003-03-07 | 2003-03-07 | |
US60/452,545 | 2003-03-07 | ||
PCT/IL2003/000681 WO2004016731A2 (en) | 2002-08-19 | 2003-08-17 | Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2005200679A Division AU2005200679B2 (en) | 2002-08-19 | 2005-02-16 | Ex-Vivo Expansion of Hematopoietic Stem Cell Populations in Mononuclear Cell Cultures |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003250519A8 true AU2003250519A8 (en) | 2004-03-03 |
AU2003250519A1 AU2003250519A1 (en) | 2004-03-03 |
Family
ID=56290470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003250519A Abandoned AU2003250519A1 (en) | 2002-08-19 | 2003-08-17 | Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1534820A4 (en) |
JP (1) | JP2006508692A (en) |
AU (1) | AU2003250519A1 (en) |
BR (1) | BR0314402A (en) |
CA (1) | CA2495824A1 (en) |
MX (1) | MXPA05001992A (en) |
WO (1) | WO2004016731A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003523166A (en) | 1998-09-29 | 2003-08-05 | ガミダ セル リミテッド | Methods for controlling proliferation and differentiation of stem and progenitor cells |
IL152904A0 (en) | 2002-01-24 | 2003-06-24 | Gamida Cell Ltd | Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations |
EP1465982A4 (en) | 2002-01-25 | 2006-06-07 | Gamida Cell Ltd | Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby |
AU2004217699B2 (en) * | 2003-03-07 | 2008-07-03 | Gamida-Cell Ltd. | Expansion of renewable stem cell populations using modulators of PI 3-kinase |
US8361976B2 (en) | 2004-07-09 | 2013-01-29 | University Of Massachusetts | Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules |
KR20080072748A (en) * | 2005-11-29 | 2008-08-06 | 가미다-셀 리미티드 | Methods of improving stem cell homing and engraftment |
US8846393B2 (en) | 2005-11-29 | 2014-09-30 | Gamida-Cell Ltd. | Methods of improving stem cell homing and engraftment |
JP5646990B2 (en) | 2007-04-23 | 2014-12-24 | ストワーズ インスティテュート フォー メディカル リサーチ | Methods and compositions for stem cell self-renewal |
JP5431361B2 (en) | 2008-01-09 | 2014-03-05 | セルカ ゲーエムベーハー | Improved culture medium additive and method of using the same |
CA2863795A1 (en) | 2012-02-13 | 2013-08-22 | Gamida-Cell Ltd. | Culturing of mesenchymal stem cells |
US9567569B2 (en) | 2012-07-23 | 2017-02-14 | Gamida Cell Ltd. | Methods of culturing and expanding mesenchymal stem cells |
US9175266B2 (en) | 2012-07-23 | 2015-11-03 | Gamida Cell Ltd. | Enhancement of natural killer (NK) cell proliferation and activity |
KR20190063468A (en) * | 2016-09-30 | 2019-06-07 | 포세이다 테라퓨틱스, 인크. | Modified stem cell memory T cells, methods for their manufacture and methods of use |
US20190119636A1 (en) | 2017-10-23 | 2019-04-25 | Poseida Therapeutics, Inc. | Modified stem cell memory t cells, methods of making and methods of using same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1485464A4 (en) * | 2002-03-18 | 2006-11-29 | Gamida Cell Ltd | Methods of inducing differentiation in ex vivo expanded stem cells |
-
2003
- 2003-08-17 CA CA002495824A patent/CA2495824A1/en not_active Abandoned
- 2003-08-17 AU AU2003250519A patent/AU2003250519A1/en not_active Abandoned
- 2003-08-17 EP EP03787995A patent/EP1534820A4/en not_active Withdrawn
- 2003-08-17 MX MXPA05001992A patent/MXPA05001992A/en active IP Right Grant
- 2003-08-17 BR BR0314402-0A patent/BR0314402A/en not_active Application Discontinuation
- 2003-08-17 WO PCT/IL2003/000681 patent/WO2004016731A2/en not_active Application Discontinuation
- 2003-08-17 JP JP2005502022A patent/JP2006508692A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
BR0314402A (en) | 2005-07-19 |
JP2006508692A (en) | 2006-03-16 |
WO2004016731A2 (en) | 2004-02-26 |
WO2004016731A3 (en) | 2004-09-10 |
EP1534820A4 (en) | 2006-04-26 |
EP1534820A2 (en) | 2005-06-01 |
AU2003250519A1 (en) | 2004-03-03 |
CA2495824A1 (en) | 2004-02-26 |
MXPA05001992A (en) | 2005-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003295444A8 (en) | Methods for in vitro expansion of hematopoietic stem cells | |
AU2003250519A8 (en) | Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures | |
EP1465982A4 (en) | Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby | |
EP1668109A4 (en) | Hematopoietic stem cells treated by in vitro fucosylation and methods of use | |
HK1090086A1 (en) | Modulation of stem and progenitor cell differentiation, assays, and uses thereof | |
AU2003216058A8 (en) | Mammalian neural stem cells, compositions and uses thereof | |
GB2405642B (en) | Methods of regulating differentiation in stem cells | |
IL167498A (en) | Methods of increasing platelet and hematopoietic stem cell production | |
WO2007028079A3 (en) | Methods of stimulating expansion of hematopoietic stem cells | |
AUPS112802A0 (en) | Methods of inducing differentiation of stem cells into a specific cell lineage | |
AU2003260351A8 (en) | Cell culture insert | |
AU2003273332A8 (en) | Method of enhancing proliferation and/or hematopoietic differentiation of stem cells | |
EP1557461A4 (en) | Composition for culturing multipotent stem cells and utilization of the same | |
AU2003296432A8 (en) | Methods and compositions for inhibiting the growth of hematopoietic malignant cells | |
IL165969A0 (en) | Medium for culturing aurologous human progenitor stem cells and applications thereof | |
EP1445311A4 (en) | Method of amplyfying hematopoietic stem cells | |
IL164507A0 (en) | Enhancement of hematopoietic stem cell survival | |
EP1608409A4 (en) | Peptides selectively lethal to malignant and transformed mammalian cells | |
SI1542714T1 (en) | Methods of increasing platelet and hematopoietic stem cell production | |
AU2003225076A8 (en) | Inhibition of ii expression in mammalian cells | |
AU2002368450A1 (en) | Radioablation of hemolymphopoietic cell populations | |
AU2003208843A1 (en) | Method of single cell cloning in eukaryotic cell culture | |
ZA200408367B (en) | Modulation of stem and progenitor cell differentiation, assays, and uses thereof | |
GB2394477B (en) | Cell culture | |
EP1497434A4 (en) | Matrix analysis of gene expression in cells (magec) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |